RT Journal Article
SR Electronic
T1 Population Estimates of People with Spina Bifida in the United States in 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.03.22268639
DO 10.1101/2022.02.03.22268639
A1 Virginia G. Briggs
YR 2022
UL http://medrxiv.org/content/early/2022/02/03/2022.02.03.22268639.abstract
AB Introduction Spina bifida is a birth defect that results in deficits of neurological function. Individuals diagnosed with spina bifida often require a lifetime of medical care to manage this condition. Currently, the number of people living with spina bifida in the United States is unclear. The purpose of this study is to provide estimates of the magnitude of this condition, and its distribution by gender and age.Methods Total births affected by spina bifida were calculated using rates from the Birth Defects Monitoring Program (BDMP) and state-based birth defects tracking systems supported by the Centers for Disease Control (CDC), over an 80-year period (1940-2020). Spina bifida mortality rates were determined using death certificate data available through the Centers for Disease Control and Prevention, National Center for Health Statistics. Life tables were created for each year of birth between 1940 and 2020 to estimate the total number of people with spina bifida alive in 2020 in the United States.Results In 2020, the estimated number of people in the U.S. living with spina bifida (0-80 years of age) was 124,150 (67,662 female; 56,488 male). The majority were adults aged 30 to 80 years (66.6%), compared to children and young adults (33.4%).Conclusion Understanding the approximate size and distribution by age and gender may assist health care providers in planning services for this changing population.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThere are no clinical trials associated with this study.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Information on total live births and deaths in the United States can be obtained through the National Center for Health Statistics at the Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/nchs/data-visualization/natality-trends/index.htm http://wonder.cdc.gov/cmf-icd8.html http://wonder.cdc.gov/cmf-icd9.html http://wonder.cdc.gov/mcd-icd10.html I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used for this study are available online at: 1)https://www.cdc.gov/nchs/data-visualization/natality-trends/index.htm 2)http://wonder.cdc.gov/cmf-icd8.html 3)http://wonder.cdc.gov/cmf-icd9.html 4)http://wonder.cdc.gov/mcd-icd10.html https://www.cdc.gov/nchs/data-visualization/natality-trends/index.htm http://wonder.cdc.gov/cmf-icd8.html http://wonder.cdc.gov/cmf-icd9.html http://wonder.cdc.gov/mcd-icd10.html